Skip Navigation

JNCI Journal of the National Cancer Institute 2001 93(15):1132; doi:10.1093/jnci/93.15.1132
© 2001 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Miller, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 93, No. 15, 1132, August 1, 2001
© 2001 Oxford University Press

NEWS

Enrollment Begins for Largest-Ever Prostate Cancer Prevention Trial

Mike Miller

In late July, the National Cancer Institute and the Southwest Oncology Group launched the first study designed to look directly at the effects of vitamin E and selenium, both separately and together, in preventing prostate . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JCOHome page
S. Wilkinson and G. W. Chodak
Critical Review of Complementary Therapies for Prostate Cancer
J. Clin. Oncol., June 1, 2003; 21(11): 2199 - 2210.
[Abstract] [Full Text] [PDF]